Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
AstraZeneca
AZN
|
$677M |
| 2 |
Tesla
TSLA
|
$374M |
| 3 |
Constellation Brands
STZ
|
$357M |
| 4 |
NVIDIA
NVDA
|
$292M |
| 5 |
Meta Platforms (Facebook)
META
|
$264M |
Top Sells
| 1 |
Netflix
NFLX
|
$892M |
| 2 |
Charter Communications
CHTR
|
$838M |
| 3 |
AbbVie
ABBV
|
$553M |
| 4 |
Bristol-Myers Squibb
BMY
|
$488M |
| 5 |
FedEx
FDX
|
$418M |
Sector Composition
| 1 | Technology | 21.08% |
| 2 | Consumer Discretionary | 17.73% |
| 3 | Financials | 13.26% |
| 4 | Healthcare | 11.95% |
| 5 | Communication Services | 11.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nike
NKE
$110B
| $1.17B | 1.15% |
14,740,623
+3,087,189
| +26% | +$246M |
|
|
RHT
27
DELISTED
Red Hat Inc
RHT
| $1.1B | 1.07% |
8,189,596
-543,061
| -6% | -$73M |
|
28
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.09B | 1.06% |
11,588,631
-174,192
| -1% | -$16.4M |
|
|
ATVI
29
DELISTED
Activision Blizzard Inc.
ATVI
| $1.07B | 1.04% |
14,028,413
-1,036,182
| -7% | -$79.1M |
|
30
McDonald's
MCD
$225B
| $1.04B | 1.01% |
6,623,167
-117,029
| -2% | -$18.3M |
|
31
Corpay
CPAY
$22.3B
| $969M | 0.94% |
4,598,370
+577,206
| +14% | +$122M |
|
|
32
Bristol-Myers Squibb
BMY
$96.8B
| $965M | 0.94% |
17,446,314
-8,827,109
| -34% | -$488M |
|
33
Goldman Sachs
GS
$220B
| $938M | 0.91% |
4,253,241
-1,487,487
| -26% | -$328M |
|
34
Workday
WDAY
$62B
| $902M | 0.88% |
7,448,551
-82,779
| -1% | -$10M |
|
35
PNC Financial Services
PNC
$80.1B
| $881M | 0.86% |
6,520,884
+353,976
| +6% | +$47.8M |
|
36
Caterpillar
CAT
$193B
| $874M | 0.85% |
6,442,611
+327,470
| +5% | +$44.4M |
|
37
Vertex Pharmaceuticals
VRTX
$101B
| $861M | 0.84% |
5,063,007
-1,712,321
| -25% | -$291M |
|
38
Texas Instruments
TXN
$175B
| $759M | 0.74% |
6,882,492
-1,408,751
| -17% | -$155M |
|
39
Parker-Hannifin
PH
$94.5B
| $757M | 0.74% |
4,857,675
-440,509
| -8% | -$68.7M |
|
|
CXO
40
DELISTED
CONCHO RESOURCES INC.
CXO
| $752M | 0.73% |
5,438,002
-270,771
| -5% | -$37.5M |
|
|
ALXN
41
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $748M | 0.73% |
6,028,122
-1,459,471
| -19% | -$181M |
|
|
SPLK
42
DELISTED
Splunk Inc
SPLK
| $702M | 0.68% |
7,082,607
-957,102
| -12% | -$94.9M |
|
43
Albemarle
ALB
$9.35B
| $692M | 0.67% |
7,330,974
+1,290,510
| +21% | +$122M |
|
|
44
AstraZeneca
AZN
$254B
| $677M | 0.66% |
+19,274,167
| New | +$677M |
|
|
45
FedEx
FDX
$52.8B
| $642M | 0.63% |
2,828,926
-1,840,786
| -39% | -$418M |
|
46
Monster Beverage
MNST
$61.7B
| $605M | 0.59% |
10,550,069
-1,682,800
| -14% | -$96.4M |
|
|
47
Constellation Brands
STZ
$26B
| $460M | 0.45% |
2,101,846
+1,629,361
| +345% | +$357M |
|
|
CELG
48
DELISTED
Celgene Corp
CELG
| $435M | 0.42% |
5,479,822
-3,287,290
| -37% | -$261M |
|
|
XYZ
49
Block, Inc.
XYZ
$46.2B
| $426M | 0.42% |
6,918,122
-2,235,053
| -24% | -$138M |
|
50
Exelon
EXC
$43.6B
| $307M | 0.3% |
7,208,111
+52,218
| +0.7% | +$2.22M |
|